Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Autism Spectrum Disorder
20%
Cell Behavior
20%
Cell Membrane
20%
Cell-based
100%
Cellular Efflux
20%
Chemical Scaffolds
20%
Family Members
20%
Flux Assay
20%
Fragile X Mental Retardation 1 (FMR1)
40%
Fragile X Mental Retardation Protein
80%
Fragile X Syndrome
100%
Gene Silencing
20%
HEK293 Cells
20%
High-throughput Screening
40%
Higher Brain Dysfunction
20%
Hit Optimization
20%
Holistic Evaluation
20%
Ion Channel Activity
20%
Ion Channels
80%
KCNT1
20%
Medicinal Chemistry
20%
Membrane Permeability
20%
Membrane Potential
20%
Molecular Targets
20%
Monogenic
20%
Neuronal Activity
20%
Novel Treatments
20%
Optimization Approach
20%
Pharmacotherapy
20%
Potassium Channel
100%
Potential Treatments
20%
Protein Expression
20%
RNA-binding Protein
20%
Screening Approach
20%
Slack Channel
60%
Small Molecule Activation
100%
Small Molecules
40%
Structure-activity Relationship
20%
Study Activation
20%
Synthesized Compounds
20%
Therapeutic Potential
20%
Tool Compound
20%
Treatment Strategy
20%
Voltage-clamp Electrophysiology
20%
Water-filled
20%
X-linked Disorder
20%
Biochemistry, Genetics and Molecular Biology
Cell Function
20%
Cell Membrane
20%
Cognition
20%
Drug Therapy
20%
Electrophysiology
20%
Gene Inactivation
20%
HEK 293 Cells
20%
High Throughput Screening
40%
Intellectual Disability
40%
Ion Channel
100%
KCNT1
20%
Membrane Permeability
20%
Membrane Potential
20%
Neuronal Activity
20%
Potassium Channel
100%
Protein Expression
20%
RNA-binding Protein
20%
Small Molecule
100%
Structure Activity Relation
20%
Voltage Clamp
20%
Pharmacology, Toxicology and Pharmaceutical Science
Autism
20%
Diseases
20%
Effusion
20%
Fragile X Mental Retardation Protein
80%
Fragile X Syndrome
100%
High-Throughput Screening
40%
Intellectual Impairment
40%
Ion Channel
100%
Molecular Target
20%
Pharmaceutical Chemistry
20%
Pharmacotherapy
20%
Potassium Channel
100%
RNA Binding Protein
20%
Structure Activity Relationship
20%
X Chromosome Linked Disorder
20%